Literature DB >> 28299060

The provider cost of treating tuberculosis in Bauchi State, Nigeria.

Nisser Umar1, Richard Fordham2, Ibrahim Abubakar3, Max Bachmnn2.   

Abstract

The study was aimed at assessing the economic cost shouldered by government, as providers, in the provision of free Tuberculosis (TB) diagnosis and treatment services in Bauchi State, northern Nigeria. A cost analysis study was designed and questionnaires administered by the principal investigators to officers in charge of 27 randomly sampled government TB services providers across the State of Bauchi. Seventeen of these centers were primary care centers, 9 secondary care providers and one was a tertiary care provider. Data was also collected from personnel and projects records in the State Ministry of Health, of Works as well as the Ministry of Budget and Planning. The cost of buildings, staff and equipment replacement, laboratory, radiology and drugs in facilities were assessed and costs attributable tuberculosis inpatient, outpatient and directly observed therapy (DOT) services were estimated from the total cost based on the proportion of TB cases in the total patient pool accessing those services. The average proportion of TB patients in facilities was 3.4% in overall, 3.3% among inpatients and 3.1% in the outpatient population. The average cost spent to treat a patient with TB was estimated at US $227.14. The cost of inpatient care averaged $16.95/patient; DOT and outpatient services was $133.34/patient, while the overhead cost per patient was $30.89. The overall cost and all computed cost elements, except for DOT services, were highest in the tertiary center and least expensive in the infectious diseases hospital partly due to the higher administrative and other overhead recurrent spending in the tertiary health facility while the lower overhead cost observed in the infectious diseases hospital could be due to the economy of scale as a result of the relative higher number of TB cases seen in the facility operating with relatively same level of resources as other facilities in the state.

Entities:  

Keywords:  HIV.; cost-analysis; tubercolosis

Year:  2011        PMID: 28299060      PMCID: PMC5345492          DOI: 10.4081/jphia.2011.e19

Source DB:  PubMed          Journal:  J Public Health Afr        ISSN: 2038-9922


  6 in total

1.  Costs and benefits of improving tuberculosis control: the case of Thailand.

Authors:  H Sawert; S Kongsin; V Payanandana; P Akarasewi; P P Nunn; M C Raviglione
Journal:  Soc Sci Med       Date:  1997-06       Impact factor: 4.634

2.  Directly observed treatment of tuberculosis. We can't afford not to try it.

Authors:  M D Iseman; D L Cohn; J A Sbarbaro
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

3.  The economic impact of tuberculosis in hospitals in New York City: a preliminary analysis.

Authors:  P S Arno; C J Murray; K A Bonuck; P Alcabes
Journal:  J Law Med Ethics       Date:  1993 Fall-Winter       Impact factor: 1.718

4.  Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective.

Authors:  J C Bell; D N Rose; H S Sacks
Journal:  AIDS       Date:  1999-08-20       Impact factor: 4.177

5.  The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis.

Authors:  A Pablos-Méndez; T R Sterling; T R Frieden
Journal:  JAMA       Date:  1996-10-16       Impact factor: 56.272

Review 6.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

Authors:  Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye
Journal:  Arch Intern Med       Date:  2003-05-12
  6 in total
  3 in total

1.  Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis.

Authors:  Rashidah T Uthman; Andrew J Sutton; Louise J Jackson; Olalekan A Uthman
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

2.  A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology.

Authors:  Lucy Cunnama; Gabriela B Gomez; Mariana Siapka; Ben Herzel; Jeremy Hill; Angela Kairu; Carol Levin; Dickson Okello; Willyanne DeCormier Plosky; Inés Garcia Baena; Sedona Sweeney; Anna Vassall; Edina Sinanovic
Journal:  Pharmacoeconomics       Date:  2020-08       Impact factor: 4.981

3.  Cost of TB services in healthcare facilities in Kenya (No 3).

Authors:  A Kairu; S Orangi; R Oyando; E Kabia; P Nguhiu; J Ong Ang O; N Mwirigi; Y V Laurence; N Kitson; I Garcia Baena; A Vassall; E Barasa; S Sweeney; L Cunnama
Journal:  Int J Tuberc Lung Dis       Date:  2021-12-01       Impact factor: 2.373

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.